PublicWire | Emerging Market Stock News
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
No Result
View All Result
PublicWire
No Result
View All Result

Home » Technology » Frelii Launches New Corporate and Investor Website

Frelii Launches New Corporate and Investor Website

Frelii Launches New Corporate and Investor Website

by Tony Allen
April 26, 2019
in Technology
Reading Time: 5 mins read
0

LEHI, Utah–(BUSINESS WIRE)–Frelii Inc. (OTCQB: FRLI) (“Frelii” or “The Company”) today announced
that it has launched a new website, which can be visited at www.frelii.com.
The objective with this new interactive website is to provide potential
clients, partners and investors an engaging and thoughtful platform to
learn about Frelii products, services and solutions while empowering
visitors to access information based on their specific interests and
industries.

The site provides information and insight into how Frelii’s advanced
artificial intelligence (AI) platform and DNA analysis is impacting
several industry segments including: Medical
Cannabis
, Precision
Medicine
, Mobile
Health Technology
, Hospital
Systems
, Corporate
Wellness
and Insurance.

“We are pleased to unveil the new Frelii corporate website to our
investors, customers, clients, partners, media and visitors who are
looking to better understand the depth and scope of our highly advanced
AI and DNA analysis technology and solutions,” said Ian Jenkins, CEO of
Frelii Inc. “The previous website was focused primarily on consumer
applications. Our objective with the new website is to improve usability
for the various industry segments we are expanding into with an engaging
and informative visitor experience. The new design provides us with a
foundation we can leverage for future growth and expansion.”

The new Frelii website will be regularly updated with news, information
and insight regarding Frelii products, strategic initiatives,
partnerships, events and industry developments.

About Frelii Inc.

Frelii Inc. is a medical technology company that uses gene sequencing
and artificial intelligence to determine risk and lifestyle
modifications. Its technology analyzes the most comprehensive markers
(60,000,000+) on the market to date. Frelii’s technology generates
accurate and profoundly valuable insight into DNA. It opens
opportunities never before realized in health care, precision medicine,
insurance, corporate wellness as well as personal health and risk
identification. For more information, please visit www.frelii.com.
Frelii (OTCQB: FRLI) trades on the #OTCQB Venture Market for early stage
and developing U.S. and international companies. Companies are current
in their reporting and undergo an annual verification and management
certification process. Investors can find Real-Time quotes and market
information for the company on www.otcmarkets.com.

Follow Frelii online at:

Frelii Facebook Page https://www.facebook.com/livefrelii/

Frelii
Twitter Feed @livefrelii

Frelii Instagram Page @livefrelii

Frelii
LinkedIn Page linkedin.com/company/frelii/

Safe Harbor Statement:

This release contains certain “forward-looking statements” relating to
the business of the Company. All statements, other than statements of
historical fact included herein are “forward-looking statements”
including statements regarding: the continued growth of the e-commerce
segment and the ability of the Company to continue its expansion into
that segment; the ability of the Company to attract customers and
partners and generate revenues; the ability of the Company to
successfully execute its business plan; the business strategy, plans,
and objectives of the Company; and any other statements of
non-historical information. These forward-looking statements are often
identified by the use of forward-looking terminology such as “believes,”
“expects” or similar expressions and involve known and unknown risks and
uncertainties. Although the Company believes that the expectations
reflected in these forward-looking statements are reasonable, they do
involve assumptions, risks, and uncertainties, and these expectations
may prove to be incorrect. Investors should not place undue reliance on
these forward-looking statements, which speak only as of the date of
this news release. The Company’s actual results could differ materially
from those anticipated in these forward-looking statements as a result
of a variety of factors, including those discussed in the Company’s
periodic reports that are filed with the Securities and Exchange
Commission and available on its website (https://www.sec.gov).
All forward-looking statements attributable to the Company or persons
acting on its behalf are expressly qualified in their entirety by these
factors. Other than as required under the securities laws, the Company
does not assume any duty to update these forward-looking statements.

Read More

Previous Post

Williams Industrial Services Appoints Steven D. Davis to Board of Directors

Next Post

DionyMed Brands Inc. Shares Approved to Trade on the OTCQB Venture Market under the Symbol ‘HMDEF’

Tony Allen

Tony Allen received a bachelor’s degree in journalism from the University of South Florida in 2011, specializing in feature writing and reporting on sports and events.

Related Posts

Technology

Apple taps TSMC’s latest tech and BYD races into Japan

September 15, 2022
0
Technology

Fortress China: Xi Jinping’s plan for economic independence

September 15, 2022
0
Technology

Patreon: fight for talent makes creator economy more costly

September 15, 2022
0
Technology

Wall Street shudders after seeing US inflation data

September 14, 2022
0
Technology

After the tech sell-off: will growth investors keep the faith?

September 14, 2022
0
Technology

UK university develops device to restore sense of touch to stroke patients

September 14, 2022
0
Next Post

DionyMed Brands Inc. Shares Approved to Trade on the OTCQB Venture Market under the Symbol ‘HMDEF’

Please login to join discussion

Subscribe To Our Newsletter

Loading
Ad
PublicWire | Emerging Market Stock News 24/7 | Investor Relations US Stock Market

© Copyright 2022 publicwire.com

Navigate Site

  • About
  • Contact Us
  • Disclaimer
  • Watch LIVE
  • Privacy Policy
  • Terms and Services
  • Contributors

Follow Us

No Result
View All Result
  • LIVE Investor News Channel
  • Cannabis
  • Energy
  • Finance
  • General
  • Medical
  • Podcasts
  • Retail
  • Technology
  • Videos

© Copyright 2022 publicwire.com

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.